These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Anti-viral immune response of allogeneic irradiation bone marrow chimeras: cytotoxic T cell responsiveness depends upon H-2 combination and infectious agent. Zinkernagel RM; Sado T; Althage A; Kamisaku H Eur J Immunol; 1984 Jan; 14(1):14-23. PubMed ID: 6198181 [TBL] [Abstract][Full Text] [Related]
3. Characterization of virus-specific cytotoxic T cell clones from allogeneic bone marrow chimeras. Pircher H; Baenziger J; Schilham M; Sado T; Kamisaku H; Hengartner H; Zinkernagel RM Eur J Immunol; 1987 Feb; 17(2):159-66. PubMed ID: 3493906 [TBL] [Abstract][Full Text] [Related]
4. The immune response of the mouse to lymphocytic choriomeningitis virus. V. High numbers of cytolytic T lymphocytes are generated in the spleen during acute infection. Moskophidis D; Assmann-Wischer U; Simon MM; Lehmann-Grube F Eur J Immunol; 1987 Jul; 17(7):937-42. PubMed ID: 2886344 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of recovery from acute virus infection. VIII. Treatment of lymphocytic choriomeningitis virus-infected mice with anti-interferon-gamma monoclonal antibody blocks generation of virus-specific cytotoxic T lymphocytes and virus elimination. Wille A; Gessner A; Lother H; Lehmann-Grube F Eur J Immunol; 1989 Jul; 19(7):1283-8. PubMed ID: 2503388 [TBL] [Abstract][Full Text] [Related]
6. Functional heterogeneity of lymphocytic choriomeningitis virus-specfic T lymphocytes. I. Identification of effector amd memory subsets. Johnson ED; Cole GA J Exp Med; 1975 Apr; 141(4):866-81. PubMed ID: 47887 [TBL] [Abstract][Full Text] [Related]
7. Induction or prevention of immunopathological disease by cloned cytotoxic T cell lines specific for lymphocytic choriomeningitis virus. Baenziger J; Hengartner H; Zinkernagel RM; Cole GA Eur J Immunol; 1986 Apr; 16(4):387-93. PubMed ID: 3084281 [TBL] [Abstract][Full Text] [Related]
8. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection. Byrne JA; Oldstone MB J Immunol; 1986 Jan; 136(2):698-704. PubMed ID: 2416821 [TBL] [Abstract][Full Text] [Related]
9. Role of the major histocompatibility complex in targeting effector T cells into a site of virus infection. Doherty PC; Allan JE Eur J Immunol; 1986 Oct; 16(10):1237-42. PubMed ID: 3490385 [TBL] [Abstract][Full Text] [Related]
10. In vivo antiviral effect of cytotoxic T lymphocyte clones specific for lymphocytic choriomeningitis virus. Cihak J Microbiologica; 1986 Jul; 9(3):333-42. PubMed ID: 3489156 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of recovery from acute virus infection. I. Role of T lymphocytes in the clearance of lymphocytic choriomeningitis virus from spleens of mice. Lehmann-Grube F; Assmann U; Löliger C; Moskophidis D; Löhler J J Immunol; 1985 Jan; 134(1):608-15. PubMed ID: 3871115 [TBL] [Abstract][Full Text] [Related]
12. Capacity of sensitized thymus-derived lymphocytes to induce fatal lymphocytic choriomeningitis is restricted by the H-2 gene complex. Doherty PC; Zinernagel RM J Immunol; 1975 Jan; 114(1 Pt 1):30-3. PubMed ID: 1078677 [TBL] [Abstract][Full Text] [Related]
13. Control of acute infection with lymphocytic choriomeningitis virus in mice that cannot present an immunodominant viral cytotoxic T lymphocyte epitope. Gegin C; Lehmann-Grube F J Immunol; 1992 Nov; 149(10):3331-8. PubMed ID: 1385522 [TBL] [Abstract][Full Text] [Related]
14. Leucyl-leucine methyl ester treatment of donor cells permits establishment of immunocompetent parent----F1 chimeras that are selectively tolerant of host alloantigens. Thiele DL; Calomeni JA; Lipsky PE J Immunol; 1987 Oct; 139(7):2137-42. PubMed ID: 3309052 [TBL] [Abstract][Full Text] [Related]
15. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants. Byrne JA; Ahmed R; Oldstone MB J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788 [TBL] [Abstract][Full Text] [Related]
16. [Genetic restriction specificity of suppressor T cell circuit--analyses by allogeneic bone marrow chimeras]. Munechika N Hokkaido Igaku Zasshi; 1985 Jul; 60(4):593-601. PubMed ID: 2414201 [TBL] [Abstract][Full Text] [Related]
17. Virus-specific cytotoxic T cell-mediated lysis of lymphocytes in vitro and in vivo. Kyburz D; Speiser DE; Aebischer T; Hengartner H; Zinkernagel RM J Immunol; 1993 Jun; 150(11):5051-8. PubMed ID: 7684417 [TBL] [Abstract][Full Text] [Related]
18. Anti-bacterial immunity to Listeria monocytogenes in allogeneic bone marrow chimera in mice. Onoé K; Good RA; Yamamoto K J Immunol; 1986 Jun; 136(11):4264-9. PubMed ID: 2871109 [TBL] [Abstract][Full Text] [Related]
19. Lack of correlation between cytotoxic T lymphocytes and lethal murine lymphocytic choriomeningitis. Pfau CJ; Saron MF; Pevear DC J Immunol; 1985 Jul; 135(1):597-602. PubMed ID: 3873496 [TBL] [Abstract][Full Text] [Related]
20. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10). Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]